Date Field | Doc. No. | Party | Description |
---|
Feb 22, 2016 | 10 | board | Decision Denying Institution Download |
Jan 20, 2016 | 9 | petitioner | Petitioner's Updated Mandatory Notice Download |
Nov 24, 2015 | 2001 | patent_own | Donald J.P. Pinto et al., Factor Xa Inhibitors- Next-Generation Antithrombotic Agents, 53 J. MED. CHEM. 6243, 6243 (2010) Download |
Nov 24, 2015 | 2010 | patent_own | Bristol-Myers Squibb Co., Quarterly Report (Form 10-Q) (Oct. 27, 2015) Download |
Nov 24, 2015 | 2005 | patent_own | Donald J.P. Pinto et al., Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo-3,4-c-pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibito Download |
Nov 24, 2015 | 2002 | patent_own | Pancras C. Wong et al., Apixaban, an Oral, Direct and Highly Selective Factor Xa Inhibitor- In Vitro, Antithrombotic and Antihemostatic Studies, 6 J. THROMBOSIS and HAEMOSTATIS 820 (2008) Download |
Nov 24, 2015 | 2003 | patent_own | Donald J.P. Pinto et al., Case History- Eliquis (Apixaban), a Potent and Selective Inhibitor of Coagulation Factor Xa for the Prevention and Treatment of Thrombotic Diseases, 47 ANN. REP. MEDICINAL CHEMISTRY 123 (2012) Download |
Nov 24, 2015 | 2007 | patent_own | Excerpts of File History for U.S. Patent No. 6,967,208 Download |
Nov 24, 2015 | 2008 | patent_own | Bengt I. Eriksson et al., Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism, 62 ANN. REV. MED. 41 (2011) Download |
Nov 24, 2015 | 2009 | patent_own | Bristol-Myers Squibb Co., Annual Report (Form 10-K) (Feb. 13, 2015) Download |
Nov 24, 2015 | 8 | patent_own | Patent Owner's Preliminary Response Download |
Nov 24, 2015 | 2006 | patent_own | Press Release, American Chemical Society, -Heroes of Chemistry- Developed Products That Improve Health, Homes and Automobiles (June 29, 2015) Download |
Nov 24, 2015 | 2004 | patent_own | Yun-Long Li et al., Preparation of 1-(3-aminobenzo-d-isoxazol-5-yl)-1H-pyrazolo-4,3-d-pyrimidin-7(6H)-ones as Potent, Selective, and Efficacious Inhibitors of Coagulation Factor Xa, 16 BIOORGANIC and MEDICINAL CHEMISTRY LETTERS 5176 (2006) Download |
Oct 22, 2015 | 7 | patent_own | Patent Owner Updated Mandatory Notice Download |
Sep 2, 2015 | 5 | potential_ | Power of Attorney Download |
Sep 2, 2015 | 6 | potential_ | Related Matters Download |
Aug 27, 2015 | 4 | board | Notice of Filing Data Accorded to Petition Download |
Aug 13, 2015 | 1009 | petitioner | Prescribing Information- Eliquis FDA Label Download |
Aug 13, 2015 | 1 | petitioner | Petition for IPR of 6,967,208 Download |
Aug 13, 2015 | 1003 | petitioner | PCT Application WO 00/39131 (Fevig I) Download |
Aug 13, 2015 | 1006 | petitioner | PCT Application WO 95/01980 Download |
Aug 13, 2015 | 1008 | petitioner | Dec of George Burton Download |
Aug 13, 2015 | 1002 | petitioner | Excerpts from File History of 6,967,208 Download |
Aug 13, 2015 | 1004 | petitioner | U.S. 6,413,980 (Fevig II) Download |
Aug 13, 2015 | 2 | petitioner | POA Download |
Aug 13, 2015 | 3 | petitioner | Power of Attorney Download |
Aug 13, 2015 | 1001 | petitioner | U.S. 6,967,208 Download |
Aug 13, 2015 | 1005 | petitioner | Excerpts from File History of 6,413,980 Download |